Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Herpes Zoster Ophthalmicus Drug Revenue 1.4 Market Analysis by Type 1.4.1 Global Herpes Zoster Ophthalmicus Drug Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Oral Drug 1.4.3 Topical Drug 1.4.4 Injectable Drug 1.5 Market by Application 1.5.1 Global Herpes Zoster Ophthalmicus Drug Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Herpes Zoster Ophthalmicus Drug Market Perspective (2015-2026) 2.2 Herpes Zoster Ophthalmicus Drug Growth Trends by Regions 2.2.1 Herpes Zoster Ophthalmicus Drug Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Herpes Zoster Ophthalmicus Drug Historic Market Share by Regions (2015-2020) 2.2.3 Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Herpes Zoster Ophthalmicus Drug Market Growth Strategy 2.3.6 Primary Interviews with Key Herpes Zoster Ophthalmicus Drug Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Herpes Zoster Ophthalmicus Drug Players by Market Size 3.1.1 Global Top Herpes Zoster Ophthalmicus Drug Players by Revenue (2015-2020) 3.1.2 Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Players (2015-2020) 3.1.3 Global Herpes Zoster Ophthalmicus Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Herpes Zoster Ophthalmicus Drug Market Concentration Ratio 3.2.1 Global Herpes Zoster Ophthalmicus Drug Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Herpes Zoster Ophthalmicus Drug Revenue in 2019 3.3 Herpes Zoster Ophthalmicus Drug Key Players Head office and Area Served 3.4 Key Players Herpes Zoster Ophthalmicus Drug Product Solution and Service 3.5 Date of Enter into Herpes Zoster Ophthalmicus Drug Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Herpes Zoster Ophthalmicus Drug Historic Market Size by Type (2015-2020) 4.2 Global Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Type (2021-2026) 5 Herpes Zoster Ophthalmicus Drug Breakdown Data by Application (2015-2026) 5.1 Global Herpes Zoster Ophthalmicus Drug Market Size by Application (2015-2020) 5.2 Global Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Herpes Zoster Ophthalmicus Drug Market Size (2015-2020) 6.2 Herpes Zoster Ophthalmicus Drug Key Players in North America (2019-2020) 6.3 North America Herpes Zoster Ophthalmicus Drug Market Size by Type (2015-2020) 6.4 North America Herpes Zoster Ophthalmicus Drug Market Size by Application (2015-2020) 7 Europe 7.1 Europe Herpes Zoster Ophthalmicus Drug Market Size (2015-2020) 7.2 Herpes Zoster Ophthalmicus Drug Key Players in Europe (2019-2020) 7.3 Europe Herpes Zoster Ophthalmicus Drug Market Size by Type (2015-2020) 7.4 Europe Herpes Zoster Ophthalmicus Drug Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size (2015-2020) 8.2 Herpes Zoster Ophthalmicus Drug Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Type (2015-2020) 8.4 Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9Key Players Profiles 9.1 Abbott 9.1.1 Abbott Company Details 9.1.2 Abbott Business Overview and Its Total Revenue 9.1.3 Abbott Herpes Zoster Ophthalmicus Drug Introduction 9.1.4 Abbott Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020)) 9.1.5 Abbott Recent Development 9.2 Novartis 9.2.1 Novartis Company Details 9.2.2 Novartis Business Overview and Its Total Revenue 9.2.3 Novartis Herpes Zoster Ophthalmicus Drug Introduction 9.2.4 Novartis Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.2.5 Novartis Recent Development 9.3 GlaxoSmithKline 9.3.1 GlaxoSmithKline Company Details 9.3.2 GlaxoSmithKline Business Overview and Its Total Revenue 9.3.3 GlaxoSmithKline Herpes Zoster Ophthalmicus Drug Introduction 9.3.4 GlaxoSmithKline Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.3.5 GlaxoSmithKline Recent Development 9.4 Fresenius 9.4.1 Fresenius Company Details 9.4.2 Fresenius Business Overview and Its Total Revenue 9.4.3 Fresenius Herpes Zoster Ophthalmicus Drug Introduction 9.4.4 Fresenius Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.4.5 Fresenius Recent Development 9.5 SteriMax 9.5.1 SteriMax Company Details 9.5.2 SteriMax Business Overview and Its Total Revenue 9.5.3 SteriMax Herpes Zoster Ophthalmicus Drug Introduction 9.5.4 SteriMax Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.5.5 SteriMax Recent Development 9.6 Cadila Pharmaceuticals 9.6.1 Cadila Pharmaceuticals Company Details 9.6.2 Cadila Pharmaceuticals Business Overview and Its Total Revenue 9.6.3 Cadila Pharmaceuticals Herpes Zoster Ophthalmicus Drug Introduction 9.6.4 Cadila Pharmaceuticals Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.6.5 Cadila Pharmaceuticals Recent Development 9.7 Shermco 9.7.1 Shermco Company Details 9.7.2 Shermco Business Overview and Its Total Revenue 9.7.3 Shermco Herpes Zoster Ophthalmicus Drug Introduction 9.7.4 Shermco Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.7.5 Shermco Recent Development 9.8 TEVA 9.8.1 TEVA Company Details 9.8.2 TEVA Business Overview and Its Total Revenue 9.8.3 TEVA Herpes Zoster Ophthalmicus Drug Introduction 9.8.4 TEVA Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.8.5 TEVA Recent Development 9.9 Cipla 9.9.1 Cipla Company Details 9.9.2 Cipla Business Overview and Its Total Revenue 9.9.3 Cipla Herpes Zoster Ophthalmicus Drug Introduction 9.9.4 Cipla Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.9.5 Cipla Recent Development 9.10 Mylan 9.10.1 Mylan Company Details 9.10.2 Mylan Business Overview and Its Total Revenue 9.10.3 Mylan Herpes Zoster Ophthalmicus Drug Introduction 9.10.4 Mylan Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 9.10.5 Mylan Recent Development 9.11 Foamix 10.11.1 Foamix Company Details 10.11.2 Foamix Business Overview and Its Total Revenue 10.11.3 Foamix Herpes Zoster Ophthalmicus Drug Introduction 10.11.4 Foamix Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 10.11.5 Foamix Recent Development 9.12 Merck 10.12.1 Merck Company Details 10.12.2 Merck Business Overview and Its Total Revenue 10.12.3 Merck Herpes Zoster Ophthalmicus Drug Introduction 10.12.4 Merck Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) 10.12.5 Merck Recent Development 10Analyst's Viewpoints/Conclusions 11Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Herpes Zoster Ophthalmicus Drug Key Market Segments Table 2. Key Players Covered: Ranking by Herpes Zoster Ophthalmicus Drug Revenue Table 3. Ranking of Global Top Herpes Zoster Ophthalmicus Drug Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Herpes Zoster Ophthalmicus Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Oral Drug Table 6. Key Players of Topical Drug Table 7. Key Players of Injectable Drug Table 8. Global Herpes Zoster Ophthalmicus Drug Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Herpes Zoster Ophthalmicus Drug Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Herpes Zoster Ophthalmicus Drug Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Herpes Zoster Ophthalmicus Drug Market Share by Regions (2015-2020) Table 12. Global Herpes Zoster Ophthalmicus Drug Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Herpes Zoster Ophthalmicus Drug Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Herpes Zoster Ophthalmicus Drug Market Growth Strategy Table 18. Main Points Interviewed from Key Herpes Zoster Ophthalmicus Drug Players Table 19. Global Herpes Zoster Ophthalmicus Drug Revenue by Players (2015-2020) (Million US$) Table 20. Global Herpes Zoster Ophthalmicus Drug Market Share by Players (2015-2020) Table 21. Global Top Herpes Zoster Ophthalmicus Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Ophthalmicus Drug as of 2019) Table 22. Global Herpes Zoster Ophthalmicus Drug by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Herpes Zoster Ophthalmicus Drug Product Solution and Service Table 25. Date of Enter into Herpes Zoster Ophthalmicus Drug Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Herpes Zoster Ophthalmicus Drug Market Size by Type (2015-2020) (Million US$) Table 28. Global Herpes Zoster Ophthalmicus Drug Market Size Share by Type (2015-2020) Table 29. Global Herpes Zoster Ophthalmicus Drug Revenue Market Share by Type (2021-2026) Table 30. Global Herpes Zoster Ophthalmicus Drug Market Size Share by Application (2015-2020) Table 31. Global Herpes Zoster Ophthalmicus Drug Market Size by Application (2015-2020) (Million US$) Table 32. Global Herpes Zoster Ophthalmicus Drug Market Size Share by Application (2021-2026) Table 33. North America Key Players Herpes Zoster Ophthalmicus Drug Revenue (2019-2020) (Million US$) Table 34. North America Key Players Herpes Zoster Ophthalmicus Drug Market Share (2019-2020) Table 35. North America Herpes Zoster Ophthalmicus Drug Market Size by Type (2015-2020) (Million US$) Table 36. North America Herpes Zoster Ophthalmicus Drug Market Share by Type (2015-2020) Table 37. North America Herpes Zoster Ophthalmicus Drug Market Size by Application (2015-2020) (Million US$) Table 38. North America Herpes Zoster Ophthalmicus Drug Market Share by Application (2015-2020) Table 39. Europe Key Players Herpes Zoster Ophthalmicus Drug Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Herpes Zoster Ophthalmicus Drug Market Share (2019-2020) Table 41. Europe Herpes Zoster Ophthalmicus Drug Market Size by Type (2015-2020) (Million US$) Table 42. Europe Herpes Zoster Ophthalmicus Drug Market Share by Type (2015-2020) Table 43. Europe Herpes Zoster Ophthalmicus Drug Market Size by Application (2015-2020) (Million US$) Table 44. Europe Herpes Zoster Ophthalmicus Drug Market Share by Application (2015-2020) Table 45. Asia-Pacific Key Players Herpes Zoster Ophthalmicus Drug Revenue (2019-2020) (Million US$) Table 46. Asia-Pacific Key Players Herpes Zoster Ophthalmicus Drug Market Share (2019-2020) Table 47. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Type (2015-2020) (Million US$) Table 48. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Share by Type (2015-2020) Table 49. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size by Application (2015-2020) (Million US$) Table 50. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Share by Application (2015-2020) Table 51. Abbott Company Details Table 52. Abbott Business Overview Table 53. Abbott Product Table 54. Abbott Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 55. Abbott Recent Development Table 56. Novartis Company Details Table 57. Novartis Business Overview Table 58. Novartis Product Table 59. Novartis Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 60. Novartis Recent Development Table 61. GlaxoSmithKline Company Details Table 62. GlaxoSmithKline Business Overview Table 63. GlaxoSmithKline Product Table 64. GlaxoSmithKline Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 65. GlaxoSmithKline Recent Development Table 66. Fresenius Company Details Table 67. Fresenius Business Overview Table 68. Fresenius Product Table 69. Fresenius Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 70. Fresenius Recent Development Table 71. SteriMax Company Details Table 72. SteriMax Business Overview Table 73. SteriMax Product Table 74. SteriMax Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 75. SteriMax Recent Development Table 76. Cadila Pharmaceuticals Company Details Table 77. Cadila Pharmaceuticals Business Overview Table 78. Cadila Pharmaceuticals Product Table 79. Cadila Pharmaceuticals Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 80. Cadila Pharmaceuticals Recent Development Table 81. Shermco Company Details Table 82. Shermco Business Overview Table 83. Shermco Product Table 84. Shermco Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 85. Shermco Recent Development Table 86. TEVA Business Overview Table 87. TEVA Product Table 88. TEVA Company Details Table 89. TEVA Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 90. TEVA Recent Development Table 91. Cipla Company Details Table 92. Cipla Business Overview Table 93. Cipla Product Table 94. Cipla Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 95. Cipla Recent Development Table 96. Mylan Company Details Table 97. Mylan Business Overview Table 98. Mylan Product Table 99. Mylan Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 100. Mylan Recent Development Table 101. Foamix Company Details Table 102. Foamix Business Overview Table 103. Foamix Product Table 104. Foamix Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 105. Foamix Recent Development Table 106. Merck Company Details Table 107. Merck Business Overview Table 108. Merck Product Table 109. Merck Revenue in Herpes Zoster Ophthalmicus Drug Business (2015-2020) (Million US$) Table 110. Merck Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Herpes Zoster Ophthalmicus Drug Market Share by Type: 2020 VS 2026 Figure 2. Oral Drug Features Figure 3. Topical Drug Features Figure 4. Injectable Drug Features Figure 5. Global Herpes Zoster Ophthalmicus Drug Market Share by Application: 2020 VS 2026 Figure 6. Hospital Pharmacies Case Studies Figure 7. Retail Pharmacies Case Studies Figure 8. Online Pharmacies Case Studies Figure 9. Herpes Zoster Ophthalmicus Drug Report Years Considered Figure 10. Global Herpes Zoster Ophthalmicus Drug Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Herpes Zoster Ophthalmicus Drug Market Share by Regions: 2020 VS 2026 Figure 12. Global Herpes Zoster Ophthalmicus Drug Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Herpes Zoster Ophthalmicus Drug Market Share by Players in 2019 Figure 15. Global Top Herpes Zoster Ophthalmicus Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Ophthalmicus Drug as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Herpes Zoster Ophthalmicus Drug Revenue in 2019 Figure 17. North America Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Asia-Pacific Herpes Zoster Ophthalmicus Drug Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 21. Abbott Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 22. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. Novartis Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 24. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. GlaxoSmithKline Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 26. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Fresenius Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 28. SteriMax Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. SteriMax Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 30. Cadila Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Cadila Pharmaceuticals Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 32. Shermco Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Shermco Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 34. TEVA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. TEVA Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 36. Cipla Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Cipla Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 38. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Mylan Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 40. Foamix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Foamix Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 42. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Merck Revenue Growth Rate in Herpes Zoster Ophthalmicus Drug Business (2015-2020) Figure 44. Bottom-up and Top-down Approaches for This Report Figure 45. Data Triangulation Figure 46. Key Executives Interviewed

Abbott Novartis GlaxoSmithKline Fresenius SteriMax Cadila Pharmaceuticals Shermco TEVA Cipla Mylan Foamix Merck